Stock Updates

Morning Momentum: Novartis AG (NYSE:NVS)

The company in question is, Novartis AG (NYSE:NVS) currently with a stock price of 81.27 (-0.22% today). The market cap for Novartis AG is 214.27 B, and is in the sector Healthcare, and Drug Manufacturers РMajor industry. The target price for Novartis AG is 85.75. Currently Novartis AG is trading with a P/E of 30.6, and a forward P/E of 15.73. Average volume for Novartis AG is 2274.41 and so far today it is 1506195.

Performance in the last year for Novartis AG has been 5.99%. For EPS growth, Novartis AG has seen a growth of -2.80%, and is looking to grow in the next year to 10.03%. More long term stats show that EPS growth has been -5.80% over the last five years and could be 5.52% for the next five years. Novartis AG has seen sales growth quarter over quarter at -0.20%, with EPS growth quarter over quarter at -16.80%. The 20-day simple moving average is 0.17%, with the 200-day simple moving average coming to 7.87%.

Since the IPO date for Novartis AG on the 11/07/1996, Novartis AG has seen performance year to date to be 11.57%. With Novartis AG trading at 81.27, the dividend yield is 3.35%, and the EPS is 2.66.

So could Novartis AG, be undervalued? Well as said before P/E is 30.6. The PEG is 5.55, P/S is 4.34 and the P/B is at 2.85. The P/cash is *TBA, with P/free cash flow at 83.05.

Novartis AG ability to deal with debt shows that the current ratio is 1, and the quick ratio is 0.7. This is with long term debt/equity at 0.34, and total debt/equity at 0.46.

In terms of margins, Novartis AG has a gross margin of 65.30%, an operating margin of 15.50% and a profit margin of 12.90%.Payout ratio for Novartis AG is 101.50%. Return on assets come to 4.80% with return on investment coming to 7.30%.

Insider ownership for Novartis AG, is at 9.30% and institutional ownership comes to 11.30%. Outstanding shares are at 2636.58. While shares float is 2533.08. The float short is currently 0.18%, and short ratio is 1.96.

Graphs: Novartis AG NYSE: NVS | Thursday June 15, 2017


Novartis AG NYSE: NVS




Novartis AG NYSE: NVS

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment